BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17336752)

  • 1. Significance of additional ST segment elevation in patients with no reflow after angioplasty for acute myocardial infarction.
    Carrabba N; Parodi G; Valenti R; Shehu M; Migliorini A; Santoro GM; Antoniucci D
    J Am Soc Echocardiogr; 2007 Mar; 20(3):262-9. PubMed ID: 17336752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute anterior myocardial infarction: increased dye intensity in the myocardial risk area after coronary angioplasty is associated with reduction of diastolic volumes.
    Destro G; Marino P; Carletti M; Barbieri E; Sesana M; Golia G; Anselmi M; Zardini P
    Cardiologia; 1999 Dec; 44(12):1039-46. PubMed ID: 10687253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is Q-wave on admission associated with microvascular injury in patients with acute myocardial infarction treated with primary angioplasty?].
    Dobrzycki S; Korecki J; Kozuch M; Kamiński K; Latocha-Korecka G; Poniatowski B; Filipczuk P; Mazur M; Gorlo A; Musiał WJ
    Przegl Lek; 2004; 61(9):891-4. PubMed ID: 15803893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of early dobutamine echocardiography in patients with acute myocardial infarction treated with primary coronary angioplasty.
    Tomaszuk-Kazberuk A; Musiał WJ; Dobrzycki S; Korecki J
    Kardiol Pol; 2005 Dec; 63(6):613-9; discussion 620-1. PubMed ID: 16380861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiographic diastolic dysfunction and magnetic resonance infarct size in healed myocardial infarction treated with primary angioplasty.
    Barbieri A; Bursi F; Politi L; Rossi L; Fiocchi F; Ligabue G; Pingitore A; Positano V; Torricelli P; Modena MG
    Echocardiography; 2008 Jul; 25(6):575-83. PubMed ID: 18422674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of distal protection with the GuardWire Plus during primary angioplasty for acute myocardial infarction.
    Kawaguchi R; Hoshizaki H; Hiratsuji T; Seki R; Tada H; Adachi H; Toyama T; Naito S; Oshima S; Taniguchi K
    J Cardiol; 2005 Mar; 45(3):99-106. PubMed ID: 15801274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction.
    Fearon WF; Shah M; Ng M; Brinton T; Wilson A; Tremmel JA; Schnittger I; Lee DP; Vagelos RH; Fitzgerald PJ; Yock PG; Yeung AC
    J Am Coll Cardiol; 2008 Feb; 51(5):560-5. PubMed ID: 18237685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
    Hudson MP; Armstrong PW; Ruzyllo W; Brum J; Cusmano L; Krzeski P; Lyon R; Quinones M; Theroux P; Sydlowski D; Kim HE; Garcia MJ; Jaber WA; Weaver WD
    J Am Coll Cardiol; 2006 Jul; 48(1):15-20. PubMed ID: 16814643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ST changes before and during primary percutaneous coronary intervention predict final infarct size in patients with ST elevation myocardial infarction.
    Terkelsen CJ; Kaltoft AK; Nørgaard BL; Bøttcher M; Lassen JF; Clausen K; Nielsen SS; Thuesen L; Nielsen TT; Bøtker HE; Andersen HR
    J Electrocardiol; 2009; 42(1):64-72. PubMed ID: 18984067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of direct stenting on epicardial and myocardial perfusion in patients with acute ST segment elevation myocardial infarction.
    Gasior M; Gierlotka M; Pres D; Lekston A; Zebik T; Hawranek M; Tajstra M; Stasik-Pres G; Kalarus Z; Poloński L
    Kardiol Pol; 2007 May; 65(5):503-12; discussion 513-4. PubMed ID: 17577847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of primary percutaneous coronary interventions for stent thrombosis.
    Parodi G; Memisha G; Bellandi B; Valenti R; Migliorini A; Carrabba N; Vergara R; Antoniucci D
    Am J Cardiol; 2009 Apr; 103(7):913-6. PubMed ID: 19327415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High cholesterol in patients with ECG signs of no-reflow after myocardial infarction.
    Dobrzycki S; Kozuch M; Kamiński K; Korecki J; Ostasz A; Podgrudna E; Bonda T; Musiał WJ
    Rocz Akad Med Bialymst; 2003; 48():118-22. PubMed ID: 14737956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina.
    Karila-Cohen D; Czitrom D; Brochet E; Faraggi M; Seknadji P; Himbert D; Juliard JM; Assayag P; Steg PG
    Eur Heart J; 1999 Dec; 20(23):1724-30. PubMed ID: 10562480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of microvascular reperfusion on prognosis and left ventricular function in anterior wall myocardial infarction treated with primary angioplasty.
    Araszkiewicz A; Lesiak M; Grajek S; Prech M; Grygier M; Mularek-Kubzdela T; Cieslinski A
    Int J Cardiol; 2007 Jan; 114(2):183-7. PubMed ID: 16793152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction.
    Niccoli G; Lanza GA; Spaziani C; Altamura L; Romagnoli E; Leone AM; Fusco B; Trani C; Burzotta F; Mazzari MA; Mongiardo R; Biasucci LM; Rebuzzi AG; Crea F
    Int J Cardiol; 2007 May; 117(3):306-11. PubMed ID: 16859772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac death and heart failure following primary angioplasty in extensive myocardial infarction: incremental prognostic value of clinical, functional and angiographic data.
    Corrada E; Bigi R; Colombo P; Bossi I; De Biase AM; Mafrici A; Parodi O; Klugmann S
    Ital Heart J; 2004 Dec; 5(12):912-8. PubMed ID: 15706996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.